Breast/ovarian cancer
1 – 10 of 170
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2026
-
Mark
Dynamic assessment of proliferation to guide response-adapted therapy in the setting of neoadjuvant chemotherapy in ER+/HER2- breast cancer
- Contribution to journal › Article
-
Mark
Changes in Epithelial Ovarian Cancer Treatment and Advent of Maintenance Therapy From Real-World Data
- Contribution to journal › Article
-
Mark
Serum Levels of Thyroid Hormones in Relation to Breast Cancer Prognosis: A Multicentre Cohort Study
- Contribution to journal › Article
-
Mark
Iron deficiency restrains short-term recovery in patients undergoing surgery for advanced ovarian cancer
- Contribution to journal › Article
-
Mark
Kunskap om ärftlig cancer – inte kopplad till långvarig oro eller sämre livskvalitet
- Contribution to specialist publication or newspaper › Specialist publication article
-
Mark
Exploring survival-associated transcriptomic subtypes in ovarian cancer using RNAseq from FFPE tissues in a clinical trial cohort
- Contribution to journal › Article
-
Mark
Surgical Outcomes After Risk-Reducing Mastectomy Among BRCA1 and BRCA2 Carriers
- Contribution to journal › Article
-
Mark
Quality of life, anxiety and cancer worry following hereditary cancer testing: a 6-month Swedish follow-up study
- Contribution to journal › Article
-
Mark
Homologous recombination deficiency in primary ER-positive and HER2-negative breast cancer
- Contribution to journal › Article
-
Mark
Multiomics assessment of lung adenocarcinoma subtypes defined through tumor purity-adjusted DNA methylation
- Contribution to journal › Article
